Myths & Facts: Melanoma
While the incidence of melanoma has stabilized over the past five years, the number of people diagnosed is still alarming.
Update on Treating PTSD
not a new condition, PTSD continues to affect many people who require new treatments to allow them to lead as normal a life as possible.
Immunity Debt: A Catalyst for the Development of Infections and Autoimmune Disease?
Are precautions to stop the spread of COVID-19 now causing other widespread illness?
The Promise of mRNA Vaccines for Disease Prevention
Using mRNA technology, the same science that developed mRNA COVID-19 vaccines, Pfizer and Moderna are testing multiple vaccines to prevent diseases that cause millions of deaths each year.
Weight Loss with Intermittent Fasting?
A growing trend for shedding unwanted pounds, this weight-loss technique may help many achieve their goals.
Rules and Regulations Affecting Revenue
A number of payment rule changes and unknown future federal and state regulations loom ahead.
Putting Patients First
Value-based healthcare prioritizes positive outcomes and positions patients at the center of future healthcare systems.
Advances in Diagnostic Testing for Antimicrobial Resistance
The threat of antimicrobial resistance has increased substantially since the start of the COVID-19 pandemic, and while a host of diagnostic tools are available, these life-threatening infections still pose a threat due to limitations of tests, especially those that are rapid.
COVID-19 Testing: Vitally Important Despite Vaccines
Due to the urgency in encouraging the public to get vaccinated against the SARS-CoV-2 virus, the message concerning the importance of widespread testing has been neglected, creating a lack of data needed for study by scientists.
Neonatal Fc Receptor Blockers for Myasthenia Gravis: The Concept Is Now Reality
While acetylcholinesterase inhibitors, corticosteroids and thymectomy are generally considered first-line therapies for MG, many patients additionally require proven immunosuppressive therapies (ISTs) such as azathioprine, cyclosporine/tacrolimus or mycophenolate mofetil, or immunomodulatory therapies, including intravenous immune globulin (IVIG) or plasma exchange (PLEX).
